Publications by authors named "Alexandre Michaux"

Claim this Profile
C
Clinical Grade Manufacture of CYAD-101, a NKG2D-based, First in Class, Non-Gene-edited Allogeneic CAR T-Cell Therapy.
Alexandre Michaux, Sébastien Mauën, Eytan Breman, Marie-Sophie Dheur, Laure Twyffels

J Immunother· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Antigens Recognized by Cytolytic T Lymphocytes on Tumors.
Nathalie Vigneron, Vincent Stroobant, Wenbin Ma, Alexandre Michaux, Benoît J Van den Eynde

Methods Mol Biol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming Target Driven Fratricide for T Cell Therapy.
Eytan Breman, Benjamin Demoulin, Sophie Agaugué, Sebastien Mauën, Alexandre Michaux

Front Immunol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A spliced antigenic peptide comprising a single spliced amino acid is produced in the proteasome by reverse splicing of a longer peptide fragment followed by trimming.
Alexandre Michaux, Pierre Larrieu, Vincent Stroobant, Jean-François Fonteneau, Francine Jotereau

J Immunol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying source proteins for MHC class I-presented peptides.
Nathalie Vigneron, Wenbin Ma, Alexandre Michaux, Benoît J Van den Eynde

Methods Mol Biol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inefficient exogenous loading of a tapasin-dependent peptide onto HLA-B*44:02 can be improved by acid treatment or fixation of target cells.
Vincent Stroobant, Nathalie Demotte, Rosalie M Luiten, Ralf M Leonhardt, Peter Cresswell, Alexandre Michaux

Eur J Immunol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis